About Vuja De Sciences

Vuja De Sciences develops cancer metastasis treatments that prevent cancer progression and recurrence. They utilize leading laboratory technologies for metastatic preclinical endpoints in combination with Comparative Oncology to de-risk and inform product development and maximize the likelihood of successful human oncology clinical trials. It approaches used for cancer maintenance therapy and adjuvant therapy target the same mechanisms applied to either primary tumors or macro-metastatic tumors.